Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/146668
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNg, Tat Mingen_US
dc.contributor.authorTan, Sock Hoonen_US
dc.contributor.authorHeng, Shi Thongen_US
dc.contributor.authorTay, Hui Linen_US
dc.contributor.authorYap, Min Yien_US
dc.contributor.authorChua, Boon Houen_US
dc.contributor.authorTeng, Christine B.en_US
dc.contributor.authorLye, David C.en_US
dc.contributor.authorLee, Tau Hongen_US
dc.date.accessioned2021-03-04T07:36:19Z-
dc.date.available2021-03-04T07:36:19Z-
dc.date.issued2021-
dc.identifier.citationNg, T. M., Tan, S. H., Heng, S. T., Tay, H. L., Yap, M. Y., Chua, B. H., . . . Lee, T. H. (2021). Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore. Antimicrobial Resistance and Infection Control, 10(1), 28-. doi:10.1186/s13756-021-00898-8en_US
dc.identifier.issn2047-2994en_US
dc.identifier.other0000-0002-4570-3266-
dc.identifier.urihttps://hdl.handle.net/10356/146668-
dc.description.abstractBackground: The deployment of antimicrobial stewardship (AMS) teams to deal with the COVID-19 pandemic can lead to a loss of developed frameworks, best practices and leadership resulting in adverse impact on antimicrobial prescribing and resistance. We aim to investigate effects of reduction in AMS resources during the COVID-19 pan-demic on antimicrobial prescribing. Methods: One of 5 full-time equivalent AMS pharmacists was deployed to support pandemic work and AMS rounds with infectious disease physicians were reduced from 5 to 2 times a week. A survey in acute inpatients was con-ducted using the Global Point Prevalence Survey methodology in July 2020 and compared with those in 2015 and 2017–2019. Results: The prevalence of antimicrobial prescribing (55% in 2015 to 49% in 2019 and 47% in 2020, p = 0.02) and antibacterials (54% in 2015 to 45% in 2019 and 42% in 2020, p < 0.01) have been reducing despite the pandemic. Antimicrobial prescribing in infectious disease wards with suspected or confirmed COVID-19 cases was 29% in 2020. Overall, antimicrobial prescribing quality indicators continued to improve (e.g. reasons in notes, 91% in 2015 to 94% in 2019 and 97% in 2020, p < 0.01) or remained stable (compliance to guideline, 71% in 2015 to 62% in 2019 and 73% in 2020, p = 0.08). Conclusion: During the COVID-19 pandemic, there was no increase in antimicrobial prescribing and no significant differences in antimicrobial prescribing quality indicators.en_US
dc.language.isoenen_US
dc.relation.ispartofAntimicrobial Resistance and Infection Controlen_US
dc.rights© 2021 The Author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.en_US
dc.subjectScience::Medicineen_US
dc.titleEffects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singaporeen_US
dc.typeJournal Articleen
dc.contributor.schoolLee Kong Chian School of Medicine (LKCMedicine)en_US
dc.identifier.doi10.1186/s13756-021-00898-8-
dc.description.versionPublished versionen_US
dc.identifier.pmid33536077-
dc.identifier.scopus2-s2.0-85100353516-
dc.identifier.issue1en_US
dc.identifier.volume10en_US
dc.subject.keywordsCOVID-19en_US
dc.subject.keywordsAntimicrobial Prevalenceen_US
item.fulltextWith Fulltext-
item.grantfulltextopen-
Appears in Collections:LKCMedicine Journal Articles
Files in This Item:
File Description SizeFormat 
s13756-021-00898-8.pdf898.34 kBAdobe PDFView/Open

Page view(s)

151
Updated on Jul 4, 2022

Download(s) 50

16
Updated on Jul 4, 2022

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.